The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study.
Ana Venegas-RodríguezAna María PelloMarta López-CastilloMikel Taibo UrquíaJorge Balaguer-GermánAlicia MuntéGuillermo González-MartínSol María Carriazo-JulioJuan Martínez-MillaAndrea KallmeyerÓscar González LorenzoHans Paul Gaebelt SlockerJosé TuñónEmilio González-ParraÁlvaro AceñaPublished in: ESC heart failure (2023)
Among overweight and obese patients with HF, BIA reduces NT-proBNP levels at 90 days compared with standard care. In addition, there is a trend towards lower incidence of AKI in the BIA-guided group. Although more studies are required, BIA could be a useful tool in decompensated HF management in overweight and obese patients.